Organogenesis Holdings Inc reports results for the quarter ended in March - Earnings Summary

Organogenesis Holdings

10/05/2023 22:02

* Organogenesis Holdings Inc  ORGO.OQ  reported a quarterly
adjusted loss of 2 cents​​ per share for the quarter ended in
March. The lone analyst forecast for the quarter was for a loss
of 2 cents per share.
    * Revenue rose 9.7% to $107.64 million from a year ago;
analysts
expected $95.50 million. 
    * Organogenesis Holdings Inc's reported EPS for the quarter
was a
loss of 2 cents​.
    * The mean earnings estimate of analysts had fallen by
about 150%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Organogenesis Holdings Inc shares had risen by 4.2% this
quarter and lost 17.5% so far this year.
    * The company reported a quarterly loss of $2.97 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.02          -0.02          Met
 Dec. 31 2022      0.05           0.06           Beat
 Sep. 30 2022      0.06           0.00           Missed
 Jun. 30 2022      0.08           0.07           Missed